EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study

Nic G Reitsam, Alexander Gäble, Lisa Siebenhüter, Tina Schaller, Friederike Liesche-Starnecker, Eva Sipos, Sebastian Dintner, Christoph Walz, John Babic, Martin Trepel, Malte Kircher, Victoria E Fincke und 4 weitere

Acta Neuropathologica · 2026

DOI: 10.1007/s00401-026-02979-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2026. Verfasst von Nic G Reitsam und 15 weiteren Autor:innen. Beteiligte Einrichtung: Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany. nic.reitsam@uk-augsburg.de. Hauptthemen laut MEDLINE: Gelatinases, Serine Endopeptidases, Biomarkers, Tumor, Membrane Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universität Augsburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas and a major cause of mortality in neurofibromatosis type 1 (NF-1). Distinguishing MPNSTs from benign neurofibromas remains challenging. We investigated fibroblast activation protein alpha (FAP) as a malignancy biomarker and theranostic target in peripheral nerve sheath tumors. Therefore, we integrated publicly available bulk transcriptomics, spatial transcriptomics, and single-cell RNA sequencing with immunohistochemistry (IHC) on independent archival samples. We further directly assessed clinical translatability using FAP-targeted PET/CT in an NF-1 patient undergoing work-up for suspected malignant transformation. Across independent bulk datasets, FAP was consistently up-regulated in MPNSTs compared with neurofibromas. In the TCGA sarcoma dataset, FAP varied by histotype but was clearly expressed in MPNSTs. Spatial transcriptomics revealed enrichment of FAP -high regions in MPNSTs and co-localization with tumor cell markers. Single-cell analysis showed FAP expression in MPNST tumor cells and cancer-associated fibroblasts, with the highest levels in neural crest-like tumor subpopulations previously linked to adverse prognosis; pseudotime analysis indicated decreasing FAP expression along trajectories toward Schwann cell precursor-like states linking FAP expression to a more primitive, dedifferentiated tumor cell state. IHC confirmed strong, predominantly tumor cell-intrinsic FAP expression in MPNSTs, with minimal staining in neurofibromas and normal tissues. Plexiform neurofibromas exhibited intermediate FAP expression. In clinical imaging, FAP-PET demonstrated higher tracer uptake in histologically proven MPNSTs than in benign lesions within the same patient, including a neurofibroma that was FDG-avid but FAP-negative, supporting added diagnostic specificity over FDG-PET/CT. In summary, FAP is robustly overexpressed in MPNSTs at transcript and protein levels, potentially concentrates in high-risk tumor cell states, and is detectable by targeted PET imaging. These findings identify FAP as a clinically relevant biomarker for malignancy in NF-1-associated tumors and support implementation of FAP-directed diagnostics and therapeutics in peripheral nerve sheath tumor work-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GelatinasesSerine EndopeptidasesBiomarkers, TumorMembrane ProteinsNerve Sheath NeoplasmsCell Transformation, NeoplasticHumansFibroblast Activation Protein AlphaEndopeptidasesFemaleNeurofibromatosis 1Positron Emission Tomography Computed TomographyMaleNeurofibroma

Stichwörter der Autor:innen

FAPFibroblast activation proteinMolecular imagingNeurofibromatosis type 1Peripheral nerve sheath tumors

Substanzen

Fibroblast Activation Protein AlphaEndopeptidasesGelatinasesSerine EndopeptidasesBiomarkers, TumorMembrane Proteins

Autor:innen und Institutionen

  • Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany. nic.reitsam@uk-augsburg.de.
  • Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Germany. nic.reitsam@uk-augsburg.de.
  • Bavarian Cancer Research Center (BZKF), Augsburg, Germany. nic.reitsam@uk-augsburg.de.
  • Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
  • Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
  • Bavarian Cancer Research Center (BZKF), Augsburg, Germany.

Förderung

  • Universität Augsburg

Zitieren

APA

Reitsam, N. G., Gäble, A., Siebenhüter, L., Schaller, T., Liesche-Starnecker, F., Sipos, E., Dintner, S., Walz, C., Babic, J., Trepel, M., Kircher, M., Fincke, V. E., Johann, P. D., Märkl, B., Lapa, C., & Enke, J. S. (2026). FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study. Acta Neuropathologica. https://doi.org/10.1007/s00401-026-02979-7

Vancouver

Reitsam NG, Gäble A, Siebenhüter L, Schaller T, Liesche-Starnecker F, Sipos E, et al. FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study. Acta Neuropathologica. 2026. doi:10.1007/s00401-026-02979-7

BibTeX
@article{Reitsam2026,
  author = {Reitsam, Nic G and Gäble, Alexander and Siebenhüter, Lisa and Schaller, Tina and Liesche-Starnecker, Friederike and Sipos, Eva and Dintner, Sebastian and Walz, Christoph and Babic, John and Trepel, Martin and Kircher, Malte and Fincke, Victoria E and Johann, Pascal D and Märkl, Bruno and Lapa, Constantin and Enke, Johanna S},
  title = {FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study},
  journal = {Acta Neuropathologica},
  year = {2026},
  doi = {10.1007/s00401-026-02979-7}
}
Kostenlos starten →